Immune response to rotavirus VP4 expressed in an attenuated strain of Shigella flexneri

FEMS Immunology and Medical Microbiology

Volumn 25, Issue 3, 1999, Pages 283-288

  Loy, Adèle L ^a   Allison, Gwen ^a   Arias, Carlos F ^b   Verma, Naresh K ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

Author keywords

Fusion protein; Immunogenicity; Rotavirus; Shigella flexneri; Viral protein 4

Indexed keywords

MALTOSE BINDING PROTEIN; VIRUS PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE TRANSFER; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; ROTAVIRUS; SHIGELLA FLEXNERI; WESTERN BLOTTING;

ANIMALS; BACTERIAL VACCINES; CAPSID; CAPSID PROTEINS; CARRIER PROTEINS; DYSENTERY, BACILLARY; FEMALE; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; ROTAVIRUS; ROTAVIRUS INFECTIONS; SHIGELLA FLEXNERI; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0032780575     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00098-X     Document Type: Article

References (18)

1. Sansonetti P.J. Slaying the Hydra all at once or head by head? Nat. Med. Vaccines. 4:(Suppl.):1998;499-500.
2. Karnell A., Stocker B.A., Katakura S., Reinholt F.P., Lindberg A.A. Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterization and monkey protection studies. Vaccine. 10:1992;389-394.
3. Phalipon A., Kaufmann M., Michetti P., Cavaillon J.M., Huerre M., Sansonetti P., Kraehenbuh J.P. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J. Exp. Med. 182:1995;769-778.
4. Li A., Pal T., Forsum U., Lindberg A.A. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers. Vaccine. 10:1992;395-404.
5. Noriega F.R., Losonsky G., Wang J.Y., Formal S.B., Levine M.M. Further characterization of ΔaroA ΔvirG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli. Infect. Immun. 64:1996;23-27.
6. Hoshino Y., Kapikian A.Z. Classification of rotavirus VP4 and VP7 serotypes. Arch. Virol. 12:(Suppl.):1996;99-111.
7. Hoshino Y., Kapikian A.Z. Rotavirus antigens. Curr. Top. Microbiol. Immunol. 185:1994;179-227.
8. Taniguchi K., Maloy W.L., Nishikawa K., Green K.Y., Hoshino Y., Urasawa S., Kapikian A.Z., Chanock R.M., Gorziglia M. Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J. Virol. 62:1988;2421-2426.
9. Arias C.F., Romero P., Alvarez V., Lopez S. Trypsin activation pathway of rotavirus infectivity. J. Virol. 70:1996;5832-5839.
10. Offit P.A. Rotaviruses: immunological determinants of protection against infection and disease. Adv. Virus Res. 44:1994;161-202.
11. Arias C.F., Lizano M., Lopez S. Synthesis in Escherichia coli and immunological characterization of a polypeptide containing the cleavage sites associated with trypsin enhancement of rotavirus SA11 infectivity. J. Gen. Virol. 68:1987;633-642.
12. Lizano M., Lopez S., Arias C.F. The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus. J. Virol. 65:1991;1383-1391.
13. Mahajan N.P., Rao C.D. Nucleotide sequence and expression in E. coli of the complete P4 type VP4 from a G2 serotype human rotavirus. Arch. Virol. 141:1996;315-329.
14. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotides sequences of the M13mp18 and pUC19 vectors. Gene. 33:1985;103-119.
15. Kenny B., Haigh R., Holland I.B. Analysis of the haemolysin transport process through the secretion from Escherichia coli of PCM, CAT or β-galactosidase fused to the Hly C-terminal signal domain. Mol. Microbiol. 5:1991;2557-2568.
16. Tommassen J., Leunissen J., Van Damme-Jongsten M., Overduin P. Failure of E. coli K-12 to transport PhoE-LacZ hybrid proteins out of the cytoplasm. EMBO J. 4:1985;1041-1047.
17. Pugsley A.P. The complete general secretory pathway in Gram-negative bacteria. Microbiol. Rev. 57:1993;50-108.
18. Wick M.J., Harding C.V., Normark S.J., Pfeifer J.D. Parameters that influence the efficiency of processing antigenic epitopes expressed in Salmonella typhimurium. Infect. Immun. 62:1994;4542-4548.